Results 41 to 50 of about 2,664,817 (408)

A rare cause of multiple liver masses

open access: yesClinical Case Reports, 2021
Primary hepatic mucosa‐associated lymphoid tissue (MALT) lymphoma is a rare disease. However, if atypical hepatic masses are observed, hepatic MALT lymphoma should be considered in the differential.
Kenta Mizukoshi   +2 more
doaj   +1 more source

Role of liver biopsy in hepatocellular carcinoma

open access: yesWorld Journal of Gastroenterology, 2019
The role of liver biopsy in the diagnosis of hepatocellular carcinoma (HCC) has been challenged over time by the ability of imaging techniques to characterize liver lesions in patients with known cirrhosis.
L. di Tommaso   +6 more
semanticscholar   +1 more source

Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis

open access: yesBMJ Open Gastroenterology, 2021
Objective The decision regarding whether to perform a liver biopsy in patients with cirrhosis and clinically suspected autoimmune hepatitis (AIH) remains a challenge.
Phunchai Charatcharoenwitthaya   +2 more
doaj   +1 more source

Transjugular Liver Biopsy [PDF]

open access: yesSeminars in Interventional Radiology, 2012
Liver biopsy is considered the gold standard for the evaluation of acute and chronic liver disorders. Transjugular liver biopsy (TJLB) was described by Dotter in 1964 and clinically performed for the first time by Hanafee in 1967. TJLB consists of obtaining liver tissue through a rigid cannula introduced into one of the hepatic veins, typically using ...
Hector Ferral, George Behrens
openaire   +3 more sources

Idiopathic neonatal haemochromatosis: A case report [PDF]

open access: yes, 2011
A case of neonatal hemochromatosis is reported in a premature 35-week infant who presented at birth with coffee ground vomiting and gradual appearance of grayish icter and colorless stool.
Alaee, E., Besharat, S., Zahedpasha, Y.
core   +1 more source

Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

open access: yesClinical Liver Disease, 2019
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries, affecting nearly 25% to 30% of the general population.
Daniel Berger   +2 more
semanticscholar   +1 more source

Development and validation of a video-assisted liver biopsy technique using a minimally-invasive device

open access: yesBMC Gastroenterology, 2023
Background Percutaneous liver biopsy is the gold standard technique for establishing the cause of cirrhosis and liver disease activity assessment. However, some cases of steatohepatitis or other chronic liver diseases show a high number of false negative
Alexandra Mano Almeida   +5 more
doaj   +1 more source

Liver transplantation for type I and type IV glycogen storage disease [PDF]

open access: yes, 1993
Progressive liver failure or hepatic complications of the primary disease led to orthotopic liver transplantation in eight children with glycogen storage disease over a 9-year period.
A. G. Tzakis   +37 more
core   +1 more source

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

open access: yesGastroenterology, 2011
BACKGROUND & AIMS Prevalence of nonalcoholic fatty liver disease (NAFLD) has not been well established. The purpose of this study was to prospectively define the prevalence of both NAFLD and nonalcoholic steatohepatitis (NASH).
C. D. Williams   +7 more
semanticscholar   +1 more source

Advances in Endoscopic Ultrasound (EUS)-Guided Liver Biopsy

open access: yesDiagnostics, 2023
Recent years have seen the emergence of endoscopic-ultrasound-guided liver biopsy (EUS-LB) as an effective alternative to traditional (percutaneous or transjugular) liver biopsy techniques.
Daryl Ramai   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy